Home > Press > BASF keeps R&D spending at high level
Abstract:
* Long-term research strategy creates foundation for profitable growth
* International research Verbund with numerous cooperations secures competitive advantage
* CaRLa Catalysis Laboratory at Heidelberg University to continue successful work over the next five years
In 2010, BASF again intends to maintain its research budget at the previous years' high level, with an overall target of €1.38 billion. This was confirmed by Dr. Andreas Kreimeyer, Member of the Board of Executive Directors and Research Executive Director, at the company's Research Press Conference today, January 28, 2010, in Ludwigshafen. For the previous year 2009, BASF's research allocations reached almost €1.4 billion, slightly above the level of the previous year 2008 (€1.35 billion).
"Only with a continuous flow of innovations can we consistently use competitive advantages to achieve above-market organic growth. Continuity of research strategy is important both in good times and also in times of crisis," said Kreimeyer explaining BASF's long-term commitment. The company's R&D strategy aims to enhance the existing portfolio, develop customer-specific system solutions and deliver solutions to the challenges of the future arising from global megatrends, he continued. The complex issues to be addressed include supplying a growing world population with water, food, energy or mobility. Reflecting these technology and chemistry-relevant global trends, BASF has defined five Growth Clusters for strategic corporate research: Plant Biotechnology, White (Industrial) Biotechnology, Nanotechnology, Energy Management and Raw Material Change.
"The main drivers in achieving our ambitious research goals are our currently around 9,300 employees in Research and Development who are dedicated to transforming a pipeline brimming with about 3,300 projects into new business," emphasized Kreimeyer. It will also be necessary to respond to the paradigm shift currently underway in chemistry, whereby success will no longer be determined merely by new molecules but by new effects, new systems and system solutions, new components and functional materials. "We can only successfully tackle these complex problems through international and interdisciplinary cooperations," he explained.
Business and science cooperating for success
The importance of international knowledge networks in tackling the challenges of the future was demonstrated by presenting three of BASF's particularly successful research cooperations during the second part of the press conference. These were the Joint Innovation Lab at Ludwigshafen site which is pushing forward organic electronics, the research initiative at Harvard University in the USA devoted to preventing biofilms, and the Catalysis Research Laboratory (CaRLa) at Heidelberg University.
The joint laboratory of BASF and Heidelberg University has become a prime research location attracting catalysis researchers from around the world. Following a successful evaluation, the run time and funding of the Catalysis Research Laboratory, CaRLa for short, was extended by another five years at the beginning of the year by BASF, Heidelberg University and the State of Baden-Württemberg. At this center, corporate researchers and the university are jointly addressing basic and industrial research topics in the field of homogeneous catalysis.
Since its launch three years ago, CaRLa has become a groundbreaking pilot project for the networking of business and science. Under the motto "Industry on Campus", the laboratory gives the company additional impulses with new ideas from the academic environment of catalysis research. During the initial sponsorship period, the main emphasis was placed on projects for screening for new catalysts, including the development and improvement of catalysts for controlled hydrogenation of enones and for olefin metathesis. With the first joint patent applications and publications, the goals of accessing new raw materials and establishing even more efficient catalysts in production are coming closer to fulfillment.
####
About BASF
BASF is the world’s leading chemical company: The Chemical Company. Its portfolio ranges from chemicals, plastics and performance products to agricultural products, fine chemicals as well as oil and gas. As a reliable partner BASF helps its customers in virtually all industries to be more successful. With its high-value products and intelligent solutions, BASF plays an important role in finding answers to global challenges such as climate protection, energy efficiency, nutrition and mobility. BASF posted sales of more than €62 billion in 2008 and had approximately 97,000 employees as of the end of the year. BASF shares are traded on the stock exchanges in Frankfurt (BAS), London (BFA) and Zurich (AN).
For more information, please click here
Contacts:
Christian Böhme
Phone: +49 621 60-20130
Fax: +49 621 60-92693
Copyright © BASF
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Chemistry
Breaking carbon–hydrogen bonds to make complex molecules November 8th, 2024
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Academic/Education
Rice University launches Rice Synthetic Biology Institute to improve lives January 12th, 2024
Multi-institution, $4.6 million NSF grant to fund nanotechnology training September 9th, 2022
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
Alliances/Trade associations/Partnerships/Distributorships
Chicago Quantum Exchange welcomes six new partners highlighting quantum technology solutions, from Chicago and beyond September 23rd, 2022
University of Illinois Chicago joins Brookhaven Lab's Quantum Center June 10th, 2022
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||